Which has grown faster, CLOV or HRMY?

Over the past five years, HRMY grew revenue faster — CLOV at a 21.18% CAGR versus HRMY at 32.47%.

Is CLOV or HRMY more profitable?

HRMY runs the higher net margin — CLOV at -0.74% versus HRMY at 18.88%.

How have CLOV and HRMY total returns compared?

Over the past 5 years, CLOV delivered -8.36% and HRMY delivered 0.91% annualized total return. Past performance doesn't predict future results.

Clover Health Investments, Corp. (CLOV) vs Harmony Biosciences Holdings, Inc. (HRMY)

A side-by-side comparison of Clover Health Investments, Corp. and Harmony Biosciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CLOV

Clover Health Investments, Corp.

$2.38B

$4.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

HRMY

Harmony Biosciences Holdings, Inc.

$2.28B

$39.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CLOV vs HRMY

growth of $100 · dividends reinvested · last 6y

CLOV -54.8% (-12.4%/yr)HRMY +7.9% (+1.3%/yr)HRMY compounded faster over this window

CLOV HRMY

CLOV vs HRMY: by the numbers

•CLOV is the larger company ($2.38B vs $2.28B market cap).
•HRMY is profitable (18.88% net margin) while CLOV runs a net loss (-0.74%).
•HRMY grew revenue faster over the past five years (32.47% vs 21.18% CAGR).

Metrics side by side

Valuation

Metric	CLOV	HRMY
P/E ratio	N/A	12.78
Forward P/E	82.09	9.98
P/S ratio	0.96	2.37
P/B ratio	6.34	2.28
EV / EBITDA	N/A	7.36
FCF yield	3.11%	15.57%

Profitability

Metric	CLOV	HRMY
Gross margin	18.57%	75.42%
Operating margin	-0.74%	24.03%
Net margin	-0.74%	18.88%
ROE	-4.88%	18.14%
ROIC	-4.62%	14.96%

Growth (annualized)

Metric	CLOV	HRMY
Revenue CAGR (5Y)	21.18%	32.47%
FCF CAGR (5Y)	N/A	48.43%
Total return CAGR (5Y)	-8.36%	0.91%

Frequently asked

Which has grown faster, CLOV or HRMY?: Over the past five years, HRMY grew revenue faster — CLOV at a 21.18% CAGR versus HRMY at 32.47%.
Is CLOV or HRMY more profitable?: HRMY runs the higher net margin — CLOV at -0.74% versus HRMY at 18.88%.
How have CLOV and HRMY total returns compared?: Over the past 5 years, CLOV delivered -8.36% and HRMY delivered 0.91% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CLOV analysis Full HRMY analysis Interactive comparison tool

Dig into the metrics

Harmony Biosciences P/E ratio Clover Health Investments ROE Harmony Biosciences ROE Clover Health Investments operating margin Harmony Biosciences operating margin Clover Health Investments revenue growth Harmony Biosciences revenue growth Clover Health Investments free cash flow Harmony Biosciences free cash flow

Clover Health Investments & Harmony Biosciences appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.